HEALTH CATALYST INC's ticker is HCAT and the CUSIP is 42225T107. A total of 190 filers reported holding HEALTH CATALYST INC in Q1 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $13,528 | -18.0% | 2,117 | -3.3% | 0.00% | – |
Q1 2024 | $16,491 | +2339.5% | 2,190 | +2900.0% | 0.00% | – |
Q4 2023 | $676 | -91.0% | 73 | -90.2% | 0.00% | – |
Q3 2023 | $7,550 | -4.1% | 746 | +18.4% | 0.00% | – |
Q2 2023 | $7,875 | -33.1% | 630 | -37.5% | 0.00% | – |
Q1 2023 | $11,763 | -22.9% | 1,008 | -29.8% | 0.00% | – |
Q4 2022 | $15,265 | -73.2% | 1,436 | -75.4% | 0.00% | – |
Q3 2022 | $57,000 | -5.0% | 5,833 | +42.6% | 0.00% | – |
Q2 2022 | $60,000 | -45.9% | 4,091 | -4.2% | 0.00% | – |
Q1 2022 | $111,000 | -26.5% | 4,270 | +12.2% | 0.00% | – |
Q4 2021 | $151,000 | -34.1% | 3,807 | -17.0% | 0.00% | – |
Q3 2021 | $229,000 | -9.5% | 4,588 | +0.8% | 0.00% | – |
Q2 2021 | $253,000 | +17.7% | 4,552 | -0.8% | 0.00% | – |
Q1 2021 | $215,000 | +10.8% | 4,589 | +3.2% | 0.00% | – |
Q4 2020 | $194,000 | +14.1% | 4,445 | -4.3% | 0.00% | – |
Q3 2020 | $170,000 | +2733.3% | 4,645 | +2410.8% | 0.00% | – |
Q2 2020 | $6,000 | +50.0% | 185 | +38.1% | 0.00% | – |
Q1 2020 | $4,000 | 0.0% | 134 | +18.6% | 0.00% | – |
Q4 2019 | $4,000 | +33.3% | 113 | +6.6% | 0.00% | – |
Q3 2019 | $3,000 | – | 106 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Daventry Group, LP | 2,247,053 | $14,358,669 | 6.41% |
First Light Asset Management, LLC | 3,956,089 | $25,279,409 | 2.22% |
Nepsis Inc. | 1,253,080 | $8,007,181 | 2.16% |
Granahan Investment Management | 1,042,733 | $6,663,064 | 0.27% |
Invenomic Capital Management LP | 850,581 | $5,435,213 | 0.26% |
PIER 88 INVESTMENT PARTNERS LLC | 130,240 | $832,234 | 0.19% |
ClariVest Asset Management LLC | 285,627 | $1,825,156 | 0.19% |
KENNEDY CAPITAL MANAGEMENT LLC | 1,274,844 | $8,146,253 | 0.17% |
CVS HEALTH Corp | 32,273 | $206,221 | 0.10% |
Olympiad Research LP | 18,987 | $121,327 | 0.09% |